B.M.P. Aleman

1.1k total citations
17 papers, 730 citations indexed

About

B.M.P. Aleman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B.M.P. Aleman has authored 17 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B.M.P. Aleman's work include Cancer Treatment and Pharmacology (4 papers), Bayesian Modeling and Causal Inference (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). B.M.P. Aleman is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Bayesian Modeling and Causal Inference (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). B.M.P. Aleman collaborates with scholars based in Netherlands, Austria and United Kingdom. B.M.P. Aleman's co-authors include Henk Boot, Babs G. Taal, Linda C. van der Gaag, Cilia Witteman, Silja Renooij, Flora E. van Leeuwen, Willem J. Klokman, N.S. Russell, E.M. Noordijk and Marilyn Stovall and has published in prestigious journals such as Gastroenterology, JNCI Journal of the National Cancer Institute and Gut.

In The Last Decade

B.M.P. Aleman

16 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.M.P. Aleman Netherlands 7 381 229 182 180 89 17 730
Valerie Reed United States 16 383 1.0× 254 1.1× 286 1.6× 80 0.4× 23 0.3× 43 865
Bronislava M. Sigal United States 11 283 0.7× 211 0.9× 417 2.3× 47 0.3× 45 0.5× 18 990
Cédric Rossi France 21 458 1.2× 262 1.1× 355 2.0× 87 0.5× 53 0.6× 77 1.3k
Haider Mahdi United States 22 166 0.4× 157 0.7× 509 2.8× 387 2.1× 51 0.6× 121 1.7k
Sajid Mushtaq Pakistan 13 111 0.3× 133 0.6× 237 1.3× 92 0.5× 86 1.0× 86 602
Sukjoong Oh South Korea 13 213 0.6× 107 0.5× 252 1.4× 164 0.9× 81 0.9× 52 783
Michael J. Costa United States 23 204 0.5× 544 2.4× 369 2.0× 263 1.5× 43 0.5× 54 1.5k
Abid Irshad United States 16 270 0.7× 181 0.8× 162 0.9× 107 0.6× 116 1.3× 36 680
Elizabeth M. Azzato United States 16 142 0.4× 237 1.0× 396 2.2× 58 0.3× 47 0.5× 43 956
Peter W. Gieser United States 9 191 0.5× 284 1.2× 178 1.0× 87 0.5× 22 0.2× 9 560

Countries citing papers authored by B.M.P. Aleman

Since Specialization
Citations

This map shows the geographic impact of B.M.P. Aleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.M.P. Aleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.M.P. Aleman more than expected).

Fields of papers citing papers by B.M.P. Aleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.M.P. Aleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.M.P. Aleman. The network helps show where B.M.P. Aleman may publish in the future.

Co-authorship network of co-authors of B.M.P. Aleman

This figure shows the co-authorship network connecting the top 25 collaborators of B.M.P. Aleman. A scholar is included among the top collaborators of B.M.P. Aleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.M.P. Aleman. B.M.P. Aleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cutter, David J. & B.M.P. Aleman. (2024). Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship. Seminars in Radiation Oncology. 35(1). 27–39.
2.
Aleman, B.M.P., Naomi B. Boekel, Frances Duane, et al.. (2019). Heart Failure after Treatment for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(1). E48–E49. 1 indexed citations
3.
Aleman, B.M.P., Frederika A. van Nimwegen, Georgios Ntentas, et al.. (2016). OC-0059: A radiation dose-response relationship for risk of heart failure in survivors of Hodgkin lymphoma. Radiotherapy and Oncology. 119. S25–S26. 2 indexed citations
4.
Gaag, Linda C. van der, Silja Renooij, Cilia Witteman, B.M.P. Aleman, & Babs G. Taal. (2013). How to Elicit Many Probabilities. arXiv (Cornell University). 647–654. 24 indexed citations
5.
Boekel, Naomi B., Michael Schaapveld, Jourik A. Gietema, et al.. (2013). OC-0259: Radiotherapy/chemotherapy-related cardiovascular disease in breast cancer patients: a population-based study. Radiotherapy and Oncology. 106. S101–S101. 1 indexed citations
6.
Boekel, Naomi B., Michael Schaapveld, Jourik A. Gietema, et al.. (2012). 389 Cardiovascular Morbidity and Mortality in Patients Treated for Ductal Carcinoma in Situ of the Breast. European Journal of Cancer. 48. S156–S156. 1 indexed citations
7.
Ruskoné-Fourmestraux, A., Wolfgang Fischbach, B.M.P. Aleman, et al.. (2011). EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 60(6). 747–758. 245 indexed citations
8.
Raderer, Markus, et al.. (2011). Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. Leukemia & lymphoma. 52(12). 2262–2269. 7 indexed citations
9.
Boekel, Naomi B., Michael Schaapveld, B.M.P. Aleman, Jourik A. Gietema, & Flora E. van Leeuwen. (2010). 361 Long-term cause specific mortality in patients treated for DCIS; a population based study. European Journal of Cancer Supplements. 8(3). 163–163. 1 indexed citations
10.
Boer, Jan Paul de, et al.. (2008). Dissemination patterns in non-gastric MALT lymphoma. Haematologica. 93(2). 201–206. 47 indexed citations
11.
Leeuwen, Flora E. van, Willem J. Klokman, Marilyn Stovall, et al.. (2003). Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease. JNCI Journal of the National Cancer Institute. 95(13). 971–980. 286 indexed citations
12.
Homs, Marjolein Y.V., Ewout W. Steyerberg, Wilhelmina M.H. Eijkenboom, et al.. (2003). Is high dose rate brachytherapy an alternative to stent placement in the palliation of malignant dysphagia?ȁa randomized trial. Gastroenterology. 124(4). A104–A104. 2 indexed citations
13.
Sent, Danielle, Linda C. van der Gaag, Cilia Witteman, B.M.P. Aleman, & Babs G. Taal. (2003). On the Use of Vignettes for Eliciting Test-Selection Strategies. Studies in health technology and informatics. 95. 510–5. 1 indexed citations
14.
Gaag, Linda C. van der, Silja Renooij, Cilia Witteman, B.M.P. Aleman, & Babs G. Taal. (2002). Probabilities for a probabilistic network: a case study in oesophageal cancer. Artificial Intelligence in Medicine. 25(2). 123–148. 98 indexed citations
15.
Gaag, Linda C. van der, Silja Renooij, B.M.P. Aleman, & Babs G. Taal. (2000). Evaluation of a probabilistic model for staging of oesophageal carcinoma.. PubMed. 77. 772–6. 3 indexed citations
16.
Aleman, B.M.P., et al.. (1995). Experience with high dose rate (HDR) in bracytherapy over 100 patients with oesophageal cancer. The Netherlands Journal of Medicine. 47(2). A20–A20. 1 indexed citations
17.
Gortzak, E., et al.. (1993). Surgical intervention for complications caused by late radiation damage of the small bowel: a retrospective analysis.. PubMed. 19(4). 336–41. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026